BioMedPartners logo

BioMedPartners

Europe, Basel-Stadt, Switzerland, Basel

Description

BioMedPartners is one of the leading European venture capital firms.

Investor Profile

BioMedPartners has made 84 investments, with 1 in the past 12 months and 32% as lead.

Stage Focus

  • Series A (38%)
  • Series B (33%)
  • Series C (17%)
  • Series D (4%)
  • Series Unknown (4%)
  • Series E (2%)
  • Post Ipo Equity (1%)
  • Seed (1%)

Country Focus

  • Switzerland (51%)
  • Germany (30%)
  • United States (6%)
  • Belgium (6%)
  • France (5%)
  • The Netherlands (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Medical Device
  • Pharmaceutical
  • Health Diagnostics
  • Life Science
  • Clinical Trials
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioMedPartners frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 6
Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 8
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 8
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 8
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 16
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 9
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 7
BB Biotech Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 6
Vesalius Biocapital Partners
Europe, Luxembourg, Luxembourg, Strassen
Co-Investments: 7
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 13

Which angels does BioMedPartners often collaborate with?

DV
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1
RA
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1

What are some of recent deals done by BioMedPartners?

ImmunOs Therapeutics

Schlieren, Zurich, Switzerland

ImmunOs Therapeutics is a clinical-stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series CSep 17, 2024
Amount Raised: $11,000,000
Tubulis

Munich, Bayern, Germany

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series BMar 14, 2024
Amount Raised: $139,300,472
TOLREMO therapeutics

Zürich, Zurich, Switzerland

TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.

BiotechnologyPharmaceutical
Series ASep 20, 2023
Amount Raised: $3,790,237
Tricares

Paris, Ile-de-France, France

TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system.

Health CareMedicalMedical Device
Series CSep 16, 2022
Amount Raised: $47,075,839
ImmunOs Therapeutics

Schlieren, Zurich, Switzerland

ImmunOs Therapeutics is a clinical-stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series BJun 7, 2022
Amount Raised: $72,923,803
Tubulis

Munich, Bayern, Germany

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series BMay 3, 2022
Amount Raised: $63,152,643
Precirix

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.

BiotechnologyHealth Care
Series BMar 16, 2022
Amount Raised: $88,173,508
Scenic Biotech

Amsterdam, Noord-Holland, The Netherlands

Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.

BiometricsBiotechnologyCollaborative ConsumptionLife Science
Series AMar 10, 2022
Amount Raised: $30,837,412
Cardior Pharmaceuticals

Hanover, Niedersachsen, Germany

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

BiopharmaBiotechnologyPharmaceutical
Series BAug 25, 2021
Amount Raised: $75,344,022
Topas Therapeutics

Hamburg, Hamburg, Germany

A biotechnology company focused on developing products to address areas of major unmet need.

Advanced MaterialsBiotechnologyChemicalChemical Engineering
Series BJul 29, 2021
Amount Raised: $21,404,695